Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Generic brand for latisse?When will there be a generic loreev available?In what ways has the generic option influenced ruxolitinib's market share?Campath litigation germany?
See the DrugPatentWatch profile for Letrozole
Letrozole’s original (first) brand name is Femara, marketed for breast cancer treatment. [1]
Femara (letrozole) was originally developed and marketed by Novartis. [1]
Letrozole (including Femara) is used in hormone receptor-positive breast cancer, including: - Treatment of postmenopausal women with early breast cancer - Treatment of advanced/metastatic breast cancer - Extended adjuvant treatment in appropriate patients [1]
Yes. After the original brand, multiple generic versions of letrozole have been marketed under different names in many countries. The active ingredient is the same (letrozole), but the brand name changes. [1]
Generic letrozole is intended to be therapeutically equivalent to Femara, using the same active ingredient. Differences typically relate to manufacturing details and non-active ingredients, not the drug’s core hormone-targeting effect. [1]
Other Questions About Letrozole :